Cagrilintide 10mg

Description

Cagrilintide is a long-acting fatty acid-conjugated analog of human amylin, engineered to bind and activate amylin receptors (AMY1, AMY2, AMY3) with extended half-life characteristics compared to native amylin. Each 10mg vial is supplied as a purified lyophilized powder, sealed to preserve integrity and stability. Independent third-party testing via HPLC/UPLC-MS confirms purity at 99% or above, with bacterial endotoxin results documented for every production batch. When stored in cool, dry conditions below −20 °C, lyophilized material remains stable for 24 or more months; after reconstitution, refrigeration at 2–8 °C is recommended.

In preclinical research contexts, cagrilintide analogs have been studied for their effects on food intake regulation, gastric emptying kinetics, and body weight modulation, often as part of combination peptide protocols alongside GLP-1 receptor agonists. Its slow-release pharmacokinetic profile makes it a relevant reference material for researchers investigating amylin receptor pharmacology, complementary metabolic signaling nodes, and the mechanistic interplay between satiety hormones in rodent and in vitro model systems. For laboratory research use only. Not for human or veterinary use.